With extensive experience in developing biologics and bioconjugates, we offer a seamless service delivered by fully integrated teams, from early discovery to commercial manufacturing.
Forward-thinking and committed, we find the best solution and use the right technologies to design, develop and manufacture your products to ensure we get vital medicines to patients quickly and safely.
We are dedicated to quality excellence. We are driven to get better treatments to market, efficiently and responsibly by reducing timelines and delivering the highest quality products and services.
We are Abzena. More than a CDMO, we are a responsible and dedicated partner that takes care of your products from concept to patient.
This is a **1-year contract position** intended to provide continuity during our Empower implementation and training phase. As such, the role is intentionally execution-focused, with an emphasis on rapid onboarding, independent method execution, and advanced troubleshooting across Maurice and HPLC platforms.
The Senior Scientist, Analytical Method Development (AMD), provides temporary backfill support to ensure continuity of analytical development activities during a critical system implementation phase. This role requires a highly experienced, hands-on senior scientist capable of rapid onboarding and immediate contribution.
The ideal candidate will have deep expertise with Maurice Flex (icIEF, CE‑SDS) and Agilent HPLC systems (SEC, CEX, RP, HIC) for the analysis of biologics (mAbs, Fab, and related modalities), with demonstrated ability to independently execute methods and resolve complex technical issues.
This position works cross-functionally with Process Development (PD), AMD leadership, Quality Control (QC), and Project Management (PM) teams to support ongoing client programs and internal deliverables.
Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.
View company profile →